HB 975 prohibits licensed massage therapists, registered massage practitioners, and third parties acting on their behalf from advertising massage services that imply sexual activity, suggest prostitution services, or appear on sites known for such ads. It requires all advertising for massage therapy to include the full name and license or registration number of the specific practitioner. The bill also sets standards for permissible advertising, such as allowing business-level ads without listing individual therapists, and mandates that trade names not be deceptive. These changes directly affect massage therapy practitioners and their marketing practices in Maryland, effective October 1, 2026.
SB 910 requires Maryland health insurers to reimburse patients for services provided by graduate-level clinical interns in counseling, social work, and psychology, under specific conditions. This affects insured individuals who receive these services and insurers who must cover them. Key conditions include services being provided at outpatient facilities, interns being enrolled in accredited graduate programs, working under direct supervision of a licensed professional, and billed by the supervising provider. The bill amends existing insurance codes (Sections 15-704, 15-707, and 15-714) to add these reimbursement requirements for each profession’s interns.
This bill expands Maryland's child abuse reporting requirements by explicitly including female genital mutilation in the legal definition of abuse, which directly affects healthcare providers, educators, and other mandated reporters. It mandates that these professionals report suspected cases of female genital mutilation to authorities and increases penalties for violations while allowing individuals subjected to the procedure to file civil lawsuits for relief. The legislation also requires the Maryland Department of Health to create and distribute educational materials about female genital mutilation in partnership with various public and private organizations. Additionally, the bill authorizes health licensing boards to revoke licenses of individuals who commit violations related to female genital mutilation under specific circumstances.
HB 1094 requires Maryland health insurers to reimburse individuals for services provided by graduate-level clinical interns in counseling, social work, and psychology under specific conditions. It applies to insureds covered by policies meeting Maryland’s jurisdictional requirements (e.g., issued in-state or covering Maryland residents). Reimbursement is mandated only when interns work under direct supervision of licensed professionals at outpatient facilities and services are billed by the supervising clinician. The bill amends existing insurance codes to ensure coverage for these supervised intern services, directly affecting insurers, interns, and patients seeking mental health care.
HB 1389 updates Maryland law to explicitly include female genital mutilation (FGM) under the legal definition of "abuse" for child protection purposes. This requires healthcare workers, educators, and others to report suspected FGM cases - just like other forms of child abuse - and increases penalties for violations. The bill also allows victims to file civil lawsuits and mandates the Maryland Department of Health to create educational materials about FGM. These changes directly affect mandated reporters, medical professionals, and individuals at risk of FGM.
HB 1002 prohibits nursing facilities from involuntarily discharging or transferring residents to temporary housing (like hotels) without confirmation from the receiving facility that it can accept the resident. It requires facilities to provide residents with clear written notices at least 10 days before a discharge or transfer, including the reason, new location, and contact information for hearings. The bill also bans facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid benefits, and mandates that post-discharge plans include specific care details. These changes aim to protect residents' rights and ensure smoother transitions during involuntary moves.
SB 493 prohibits nursing facilities in Maryland from involuntarily discharging or transferring residents except for specific reasons like the resident's welfare, health improvement, or facility closure. It requires facilities to provide residents with a clear written notice at least 10 days before any involuntary discharge or transfer, detailing the reason, new location, and contact information for hearings and legal assistance. The bill also bans sending residents to temporary housing (like hotels) without confirmation from the receiving facility and prevents facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid. These changes aim to protect vulnerable residents by ensuring proper notice, preventing unfair treatment, and requiring confirmation before transfers.
HB 838 repeals a requirement that prescribers submit prescriber-pharmacist agreements to their regulating health board. Instead, it allows pharmacists (with specific qualifications, registrations, and training) to directly enter agreements authorizing them to treat opioid use disorder using controlled substances. A key provision requires pharmacists to check the Prescription Drug Monitoring Program (PDMP) for relevant patient data before starting or changing such therapy. This bill directly affects pharmacists, prescribers, and patients with opioid use disorder by expanding pharmacists' role in medication management under defined safeguards.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
SB 24 revises Maryland's Public Access Automated External Defibrillator (AED) Program to improve oversight and accessibility. It requires most organizations using public AEDs to appoint an AED coordinator responsible for maintenance, reporting, and emergency notification, while exempting law enforcement agencies from needing certificates for AEDs in patrol vehicles. The bill also repeals outdated requirements for regional AED committees and clarifies that grocery stores and restaurants are not subject to certain AED registration rules. These changes aim to streamline compliance for entities managing public AEDs, including schools, businesses, and public facilities.